← Leaderboards
Oluwaseun Johnson-Akeju
Massachusetts General Hospital
$11,498,465
Attributed
$11,729,465
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,729,465 · 3
By mechanism
R01$11,267,465 · 2
R21$462,000 · 1
Top collaborators
- Tina Mckay2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michelle Ng Gong$11,453,323
- Zhongcong Xie$19,705,169
- Linda Michele Delahanty$1,582,132
- Deborah J Wexler$3,140,359
- Elyse R Park$12,238,672
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBiological MarkersHealth Care CostsSeveritiesPostoperative DeliriumAttentionOlder PatientMortalityPerioperativeSerumImpaired CognitionHospitalizationOperative Surgical ProceduresCognitionAcuteCognitive DeficitsInvestigationIncidenceInflammation MediatorsBrain DysfunctionCritical IllnessInflammatoryBlood CirculationDiagnosis
Grant awards (10)
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II)$3,779,978
R01 · FY2025 · AG · contact PI
Minimizing ICU Neurological Dysfunction with Dexmedetomidine-induced Sleep (MINDDS II)$3,506,058
R01 · FY2024 · AG · contact PI
Investigation of a Novel Biomarker of Postoperative Delirium$252,000
R21 · FY2023 · AG · contact PI
Investigation of a Novel Biomarker of Postoperative Delirium$210,000
R21 · FY2022 · AG · contact PI
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU$626,750
R01 · FY2020 · AG · contact PI
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU$614,552
R01 · FY2020 · AG · contact PI
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU$670,819
R01 · FY2019 · AG · contact PI
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU$744,708
R01 · FY2018 · AG · contact PI
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU$744,708
R01 · FY2017 · AG · contact PI
Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU$579,892
R01 · FY2016 · AG · contact PI